![]() |
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):135-145. Published online 2022 Sep 5 DOI: https://doi.org/10.3350/cmh.2022.0181
|
Citations to this article as recorded by
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
Yu Jun Wong, Vincent L. Chen, Asim Abdulhamid, Giulia Tosetti, Huttakan Navadurong, Apichat Kaewdech, Jessica Cristiu, Michael Song, Pooja Devan, Kai Le Ashley Tiong, Jean Ee Neo, Thaninee Prasoppokakorn, Pimsiri Sripongpun, Catherine Ann Malcolm Stedman,
Hepatology.2025; 81(2): 523. CrossRef Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
Chuan Liu, Hong You, Qing-Lei Zeng, Yu Jun Wong, Bingqiong Wang, Ivica Grgurevic, Chenghai Liu, Hyung Joon Yim, Wei Gou, Bingtian Dong, Shenghong Ju, Yanan Guo, Qian Yu, Masashi Hirooka, Hirayuki Enomoto, Amr Shaaban Hanafy, Zhujun Cao, Xiemin Dong, Jing
Clinical and Molecular Hepatology.2025; 31(1): 105. CrossRef Preventing the progression of cirrhosis to decompensation and death
Càndid Villanueva, Dhiraj Tripathi, Jaume Bosch
Nature Reviews Gastroenterology & Hepatology.2025;[Epub] CrossRef Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
Yameng Sun, Wei Chen, Shuyan Chen, Xiaoning Wu, Xinxin Zhang, Lingyi Zhang, Hong Zhao, Mingyi Xu, Yongpeng Chen, Hongxin Piao, Ping Li, Lei Li, Wei Jiang, Xiaodong Li, Huichun Xing, Xudong Liu, Yuxi Zhang, Bingqiong Wang, Jialing Zhou, Tongtong Meng, Xiny
Clinical Gastroenterology and Hepatology.2024; 22(3): 591. CrossRef Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Georg Semmler, Lorenz Balcar, Benedikt Silvester Hofer, Michael Schwarz, David Bauer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Journal of Hepatology.2024; 80(5): 744. CrossRef Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients
Dmitry Victorovich Garbuzenko
World Journal of Hepatology.2024; 16(2): 126. CrossRef Role of Vibration-Controlled Transient Elastography in the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Elizabeth E. Williams, Raj Vuppalanchi
Current Hepatology Reports.2024; 23(3): 355. CrossRef Acute and non‐acute decompensation of liver cirrhosis (47/130)
Martin S. Schulz, Paolo Angeli, Jonel Trebicka
Liver International.2024;[Epub] CrossRef Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
Vishal C. Patel, Mark J. McPhail, Ruhama Uddin, Hassan Jafari, Vanessa Lawrence, Clair Le Boutillier, James Shearer, Nahel Yaziji, Angela Cape, Haroon Ahmed, Christopher Ward, Peter Walsh, Kevin Besly, Ane Zamalloa, Joanna Kelly, Ashis Mukhopadhya, Alicij
Trials.2024;[Epub] CrossRef Clinical Management practice and Therapeutic Outcomes of Chronic Liver Disease patients in the Conflicted area of North Ethiopia
Hawaz Shewatetak, Raghavendra Yarlagadda, Kotaiah Silakabattini, Ramanji Reddy Tatiparthi, Venkateswara Rao Jallepalli
Research Journal of Pharmacy and Technology.2024; : 1267. CrossRef Pharmacologic Treatment of Portal Hypertension
Yu Jun Wong, Juan G. Abraldes
Clinics in Liver Disease.2024; 28(3): 417. CrossRef Noninvasive Assessment of Portal Hypertension
Juan Bañares, Laia Aceituno, Mònica Pons, Joan Genescà
Clinics in Liver Disease.2024; 28(3): 401. CrossRef Screening for exclusion of high-risk bleeding features of esophageal varices in cirrhosis through CT and MRI
Ali Borhani, Harry Luu, Alireza Mohseni, Ziyi Xu, Mohammadreza Shaghaghi, Celestina Tolosa, Mohammad Mirza Aghazadeh Attari, Seyedeh Panid Madani, Haneyeh Shahbazian, Pegah Khoshpouri, Shadi Afyouni, Ghazal Zandieh, Ihab R. Kamel, Amy K. Kim
Clinical Imaging.2024; 110: 110168. CrossRef Performance of Baveno VII criteria for the screening of varices needing treatment in patients with biliary atresia
Yu‐Chieh Ling, Chien‐Ting Hsu, Cheng‐Yu Chen, Chi‐San Tai, Kai‐Chi Chang, Jia‐Feng Wu
Journal of Pediatric Gastroenterology and Nutrition.2024; 79(2): 222. CrossRef Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, Kuo Chao Yew, Nobuharu Tamaki, Ruveena Bhavani Rajaram, Mara Teresa Panlilio, Rashid Lui, Hye Won Lee, Jimmy Che-To Lai, Anand V. Kulkarni, Madhumita Premkumar, Cosmas Rinaldi Adithya Lesmana, Yao Chun Hsu,
Nature Reviews Gastroenterology & Hepatology.2024; 21(12): 834. CrossRef Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial
Elton Dajti, Càndid Villanueva, Annalisa Berzigotti, Anna Brujats, Agustín Albillos, Joan Genescà, Juan C. García-Pagán, Antonio Colecchia, Jaume Bosch, Càndid Villanueva, Agustín Albillos, Joan Genescà, Juan C. Garcia-Pagan, José L. Calleja, Carles Araci
Journal of Hepatology.2024;[Epub] CrossRef Meta-analysis: accuracy of the Baveno VI criteria for the diagnosis of high-risk varices in patients with hepatocellular carcinoma
Xiaoqin Zheng, Tingting Mei, Hui Xu, Heran Yin, Hua Jin, Chunyan Gou, Xiaojun Wang, Huiguo Ding
Frontiers in Oncology.2024;[Epub] CrossRef Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease
Tanvi Goyal, Michael W. Song, Deepika Suresh, Venkata S. J. Jasty, Esteban Urias, Karn Wijarnpreecha, Yu Jun Wong, Vincent L. Chen
Digestive Diseases and Sciences.2024; 69(11): 4250. CrossRef Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats, Càndid Villanueva
Clinical and Molecular Hepatology.2024; 30(4): 1055. CrossRef Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study
Shanghao Liu, Jia Li, Yujun Wong, Hyung Joon Yim, Masashi Hirooka, Hirayuki Enomoto, Qing Xie, Erhei Dai, Amr Shaaban Hanafy, Zhujun Cao, Lili Zhao, Kok Ban Teh, Tae Hyung Kim, Young Kul Jung, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima,
MedComm.2024;[Epub] CrossRef Non-invasive assessment of portal hypertension: Liver stiffness and beyond
Mattias Mandorfer, Juan G. Abraldes, Annalisa Berzigotti
JHEP Reports.2024; : 101300. CrossRef Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
Clinical and Molecular Hepatology.2023; 29(1): 188. CrossRef The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(1): 102. CrossRef Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology.2023; 29(1): 105. CrossRef Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clinical and Molecular Hepatology.2023; 29(1): 110. CrossRef Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1372. CrossRef Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik, Dong Hyun Sinn
Liver International.2023; 43(9): 1966. CrossRef Letter: Baveno‐VI criteria to exclude large varices in patients with hepatocellular carcinoma—What have we learned?
Yu J. Wong
Alimentary Pharmacology & Therapeutics.2023; 58(6): 642. CrossRef Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
Luca Rinaldi, Chiara Giorgione, Andrea Mormone, Francesca Esposito, Michele Rinaldi, Massimiliano Berretta, Raffaele Marfella, Ciro Romano
Viruses.2023; 15(8): 1730. CrossRef Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease
Yu Jun Wong, Esteban Urias, Michael W. Song, Tanvi Goyal, Wei Xuan Tay, Nicole Xinrong Han, Jing Hong Loo, Tian Yu Qiu, Karn Wijarnpreecha, Yiong Huak Chan, Vincent L. Chen
Hepatology Communications.2023;[Epub] CrossRef
|